Green Lifescience Statistics

Total Valuation

Green Lifescience has a market cap or net worth of KRW 36.60 billion. The enterprise value is 28.78 billion.

Market Cap	36.60B
Enterprise Value	28.78B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Green Lifescience has 20.00 million shares outstanding. The number of shares has decreased by -0.72% in one year.

Current Share Class	n/a
Shares Outstanding	20.00M
Shares Change (YoY)	-0.72%
Shares Change (QoQ)	-2.78%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.47
PB Ratio	0.95
P/TBV Ratio	n/a
P/FCF Ratio	87.90
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 45.03, with an EV/FCF ratio of 69.11.

EV / Earnings	-2.39
EV / Sales	1.17
EV / EBITDA	45.03
EV / EBIT	n/a
EV / FCF	69.11

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.13.

Current Ratio	3.16
Quick Ratio	2.47
Debt / Equity	0.13
Debt / EBITDA	7.68
Debt / FCF	11.80
Interest Coverage	-4.52

Financial Efficiency

Return on equity (ROE) is -27.53% and return on invested capital (ROIC) is -1.21%.

Return on Equity (ROE)	-27.53%
Return on Assets (ROA)	-1.13%
Return on Capital (ROIC)	-1.21%
Revenue Per Employee	351.48M
Profits Per Employee	-171.99M
Employee Count	70
Asset Turnover	0.46
Inventory Turnover	4.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.57%
50-Day Moving Average	2,125.26
200-Day Moving Average	2,171.66
Relative Strength Index (RSI)	29.06
Average Volume (20 Days)	73,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Green Lifescience had revenue of KRW 24.60 billion and -12.04 billion in losses. Loss per share was -611.22.

Revenue	24.60B
Gross Profit	1.48B
Operating Income	-973.86M
Pretax Income	-12.04B
Net Income	-12.04B
EBITDA	639.14M
EBIT	-973.86M
Loss Per Share	-611.22

Full Income Statement

Balance Sheet

The company has 12.73 billion in cash and 4.91 billion in debt, giving a net cash position of 7.82 billion or 391.14 per share.

Cash & Cash Equivalents	12.73B
Total Debt	4.91B
Net Cash	7.82B
Net Cash Per Share	391.14
Equity (Book Value)	36.70B
Book Value Per Share	1,922.87
Working Capital	14.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.12 billion and capital expenditures -704.29 million, giving a free cash flow of 416.38 million.

Operating Cash Flow	1.12B
Capital Expenditures	-704.29M
Free Cash Flow	416.38M
FCF Per Share	20.82

Full Cash Flow Statement

Margins

Gross margin is 6.03%, with operating and profit margins of -3.96% and -48.93%.

Gross Margin	6.03%
Operating Margin	-3.96%
Pretax Margin	-48.93%
Profit Margin	-48.93%
EBITDA Margin	2.60%
EBIT Margin	-3.96%
FCF Margin	1.69%

Dividends & Yields

Green Lifescience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.72%
Shareholder Yield	0.72%
Earnings Yield	-33.40%
FCF Yield	1.14%

Stock Splits

The last stock split was on September 5, 2023. It was a forward split with a ratio of 1.3333333333.

Last Split Date	Sep 5, 2023
Split Type	Forward
Split Ratio	1.3333333333

Scores

Green Lifescience has an Altman Z-Score of 4.95.

Altman Z-Score	4.95
Piotroski F-Score	n/a